Pierre-Olivier Grenier, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mucous Membrane | 1 | 2021 | 673 | 0.590 |
Why?
|
| Sarcoma, Kaposi | 1 | 2017 | 370 | 0.470 |
Why?
|
| Sirolimus | 1 | 2021 | 1564 | 0.450 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2017 | 657 | 0.450 |
Why?
|
| Foot | 1 | 2017 | 527 | 0.450 |
Why?
|
| Skin Diseases | 1 | 2021 | 1065 | 0.420 |
Why?
|
| Stevens-Johnson Syndrome | 2 | 2022 | 280 | 0.310 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 4149 | 0.310 |
Why?
|
| Mastocytosis, Cutaneous | 1 | 2023 | 14 | 0.240 |
Why?
|
| Vascular Malformations | 2 | 2021 | 454 | 0.230 |
Why?
|
| Mastocytosis, Systemic | 1 | 2023 | 100 | 0.210 |
Why?
|
| Lymphoma, Primary Cutaneous Anaplastic Large Cell | 1 | 2021 | 9 | 0.200 |
Why?
|
| Mastocytosis | 1 | 2023 | 160 | 0.200 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2021 | 169 | 0.170 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2017 | 95 | 0.140 |
Why?
|
| Nevus | 1 | 2017 | 204 | 0.130 |
Why?
|
| Lipoma | 1 | 2017 | 334 | 0.130 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2017 | 890 | 0.110 |
Why?
|
| Brachytherapy | 1 | 2021 | 1248 | 0.110 |
Why?
|
| Administration, Oral | 1 | 2021 | 3913 | 0.110 |
Why?
|
| Sepsis | 1 | 2022 | 2593 | 0.080 |
Why?
|
| Child | 6 | 2023 | 77709 | 0.080 |
Why?
|
| Biopsy | 1 | 2017 | 6756 | 0.060 |
Why?
|
| Infant | 3 | 2022 | 35136 | 0.060 |
Why?
|
| Skin | 1 | 2017 | 4364 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 5686 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2021 | 41006 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2021 | 25625 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2023 | 776 | 0.040 |
Why?
|
| Mouth Mucosa | 1 | 2022 | 434 | 0.040 |
Why?
|
| Adolescent | 3 | 2023 | 85781 | 0.040 |
Why?
|
| Amnion | 1 | 2020 | 209 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2020 | 652 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2022 | 77449 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 56430 | 0.030 |
Why?
|
| Male | 4 | 2021 | 350118 | 0.030 |
Why?
|
| Adult | 3 | 2022 | 214055 | 0.030 |
Why?
|
| Humans | 7 | 2023 | 744343 | 0.030 |
Why?
|
| Scoliosis | 1 | 2017 | 725 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 1416 | 0.020 |
Why?
|
| Female | 3 | 2023 | 380194 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2022 | 7729 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 213383 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2017 | 3279 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 9239 | 0.010 |
Why?
|
| Phenotype | 1 | 2017 | 16365 | 0.010 |
Why?
|